Patent intelligence · US
US 12128014
Use of thiol compounds to treat neurological disease
Use of thiol compounds to treat neurological disease
Patent details — US 12128014
- Jurisdiction
- US
- Status
- granted
- Grant date
- Oct 29, 2024
- Expiration
- Oct 24, 2044
- Applicant
- MERCAPTOR DISCOVERIES, INC.
- Claims
- 3
- CPC classes
- A61K, A61K31/095, A61K31/145, A61K31/198
Quick answer
US 12128014 (Use of thiol compounds to treat neurological disease) is held by MERCAPTOR DISCOVERIES, INC.. Status: granted. Granted Oct 29, 2024. Expires Oct 24, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- MERCAPTOR DISCOVERIES, INC.
- Grant date
- Expiration
- Claims
- 3
- CPC classes
- A61K, A61K31/095, A61K31/145, A61K31/198, A61K31/397, A61K31/40
More from MERCAPTOR DISCOVERIES, INC.
Related pharmaceutical patents in our USPTO index.
-
US 12427173
Use of bacteria, bacterial products, and other immunoregulatory entities in combination with anti-CTLA-4 and/or anti-PD-1 antibodies to treat solid tumor malignancies
granted -
US 12428415
Matriptase 2 inhibitors and uses thereof
granted -
US 12421236
Seven-membered heterocyclic derivative acting as KRAS G12C mutant protein inhibitor
granted -
US 12420085
Synergistic therapies for inter vertebral disc degeneration
granted -
US 12421231
Azaindole derivatives and their use as ERK kinase inhibitors
granted -
US 12403069
Adapter for use in a planetary mixer
granted -
US 12398179
Nanomolar peptides and derivatives to differentially modulate ephrin receptors
granted -
US 12396924
Adapter for use in a planetary mixer
granted
Frequently asked questions
What is US patent 12128014?
US 12128014 (Use of thiol compounds to treat neurological disease) is held by MERCAPTOR DISCOVERIES, INC.. Status: granted. Granted Oct 29, 2024. Expires Oct 24, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 12128014?
MERCAPTOR DISCOVERIES, INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 706 pharmaceutical patents for this assignee.
When does US 12128014 expire?
Our index shows an expiration date of Oct 24, 2044 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.